Journal Information
Statistics
Follow this link to access the full text of the article
Case and Research Letter
Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series
Eficacia a medio plazo de dupilumab en niños de ≥ 36 meses a < 12 años con dermatitis atópica: serie de casos
F.J. Melgosa Ramos
, T. Díaz Corpas, S. Martín Jiménez, A. Mateu Puchades
Corresponding author
Department of Dermatology, University Hospital Doctor Peset of Valencia, Valencia (Valencia), Spain